ProMeta: Few-shot PROTAC-targeted degradation prediction across E3 ligases
DGX agentarXiv:2609.09891v1 Announce Type: new Abstract: Proteolysis-targeting chimeras (PROTACs) have emerged as a transformative therapeutic strategy that selectively degrades historically ''undruggable'' ta